Breaking News
October 23, 2018 - Canon Medical to showcase world’s first Ultra-High Resolution CT system at ASTRO 2018
October 23, 2018 - Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients
October 23, 2018 - Cancer stem cells use ‘normal’ genes in abnormal ways
October 23, 2018 - Bad Blood: A conversation with investigative reporter John Carreyrou | News Center
October 23, 2018 - As U.S. fertility rates collapse, finger-pointing and blame follow
October 23, 2018 - Researchers develop promising targeted strategy to treat chemo-resistant blood cancer
October 23, 2018 - Pilot clinical trial shows effectiveness of bioelectronic medicine device for lupus
October 23, 2018 - Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer
October 23, 2018 - 11th World Stroke Congress examines high stroke impact in low- and middle-income countries
October 22, 2018 - Breast cancer survival could be extended with two new drug combinations
October 22, 2018 - Researchers discover how acne-causing bacteria resist treatment
October 22, 2018 - Cancer trial shows treating the prostate with radiotherapy improves survival
October 22, 2018 - New hope for a drug to treat lymphedema symptoms
October 22, 2018 - Immune-Based Treatment Helps Fight Aggressive Breast Cancer, Study Finds
October 22, 2018 - Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC
October 22, 2018 - Paternal exercise has significant impact on child’s lifelong metabolic health
October 22, 2018 - Targeting specific genomic mutation in breast cancer improves survival
October 22, 2018 - Loss of tumor protein p53 helps cancer cells grow in hostile environment
October 22, 2018 - IDT to demonstrate CRISPR expertise at European-focused events
October 22, 2018 - Breathing through the nose improves memory consolidation
October 22, 2018 - Recreational Marijuana Now Legal in Canada
October 22, 2018 - Scientists reveal drumming helps schoolchildren diagnosed with autism
October 22, 2018 - A stage IV cancer patient discusses what it means to live well with serious illness
October 22, 2018 - In Kids with Autism, Short Questionnaire May Detect GI Disorders
October 22, 2018 - Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas
October 22, 2018 - Aspirin may be effective in preventing blood clots after knee replacement
October 22, 2018 - Drug cocktail that increases lifespan discovered
October 22, 2018 - Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
October 22, 2018 - Study shows potential positive impact of group prenatal care on birth outcomes
October 22, 2018 - Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer
October 22, 2018 - Health Tip: Keep Ticks Away
October 22, 2018 - Obsessive-compulsive disorder – Genetics Home Reference
October 22, 2018 - Researchers find disrupted functional connectivity in cerebellum of adults with HF-ASD
October 22, 2018 - Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors
October 22, 2018 - Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma
October 22, 2018 - Overcoming bottlenecks in early drug discovery with the power of sound
October 22, 2018 - Scientists discover genes that contribute to ADHD development
October 22, 2018 - Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma
October 22, 2018 - FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis
October 22, 2018 - At-home biofeedback therapy effective in relieving difficult-to-treat constipation
October 22, 2018 - Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer
October 22, 2018 - People with periodontal disease less likely to reach healthy blood pressure ranges
October 22, 2018 - Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer
October 22, 2018 - Primary care doctors ‘not doing enough’ to curb STDs
October 22, 2018 - Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer
October 22, 2018 - ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress
October 22, 2018 - Study findings could set new standard of care for advanced anal cancer
October 22, 2018 - Erlotinib improves progression-free survival in EGFR mutated NSCLC
October 22, 2018 - Pain, insomnia, and depression often drive osteoarthritis patients to seek medical care
October 22, 2018 - The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award
October 22, 2018 - Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients
October 22, 2018 - Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC
October 22, 2018 - Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis
October 22, 2018 - Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients
October 22, 2018 - Prostate radiotherapy improves survival in men with low burden of metastatic disease
October 22, 2018 - Duration of respiratory disturbances may better predict mortality risk from OSA
October 22, 2018 - Free phone app helps low-income obese patients to lose weight
October 22, 2018 - Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers
October 22, 2018 - FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma
October 22, 2018 - Compression Collar May Protect Brain of Female Soccer Players
October 22, 2018 - Technique visualizes neuron communication
October 22, 2018 - Advancement in medical imaging methods for health care
October 22, 2018 - Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis
October 22, 2018 - Immunotherapy increases survival in some patients with metastatic triple negative breast cancer
October 22, 2018 - Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma
October 22, 2018 - LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer
October 22, 2018 - Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
October 22, 2018 - Not exercising is worse than smoking, diabetes or heart disease finds study
October 22, 2018 - Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer
October 22, 2018 - Map of Mouse Hippocampus Could Be Weapon Against Alzheimer’s
October 22, 2018 - Psychotropic polypharmacy is common in Alzheimer’s disease
October 22, 2018 - Texas A&M and UTA establish Texas Genomics Core Alliance
October 22, 2018 - Analyzing mouse’s potential as animal model of decision-making
October 22, 2018 - Radiotherapy can prolong survival in prostate cancer
October 22, 2018 - A genetic mutation involved in relapse
October 21, 2018 - Report reveals growing impact of cannabis on young people
October 21, 2018 - NSF awards $5 million grant to help scientists magnify societal impact of research
October 21, 2018 - Fertility Rates Down for Each Urbanization Level 2007 to 2017
October 21, 2018 - Genetically engineered 3-D human muscle transplant in a murine model
October 21, 2018 - Moms’ tight work schedules may affect their children’s sleep
New Guidelines Mean 1 in 3 Adults May Need Blood Pressure Meds

New Guidelines Mean 1 in 3 Adults May Need Blood Pressure Meds

image_pdfDownload PDFimage_print

WEDNESDAY, May 23, 2018 — One out of every three U.S. adults has high blood pressure that should be treated with medication, under guidelines recently adopted by the two leading heart health associations.

The American College of Cardiology and American Heart Association redefined high blood pressure at 130/80 in November, down from the previous level of 140/90, based on new evidence supporting a lower threshold.

Under the new guidelines, nearly 46 percent of U.S. adults now would be considered to have high blood pressure, a new study reported.

Further, 36 percent would be recommended for blood pressure medication, the study authors said.

That means the number of American adults diagnosed with high blood pressure would grow to 105 million from 74 million, and those who should be taking medication to 83 million from 72 million.

Full implementation of the new guidelines would mean 156,000 fewer deaths each year, and 340,000 fewer heart attacks, strokes and other heart-related ailments, the researchers concluded.

“Our study shows the benefit of risk reduction overweighs the potential risk of adverse events in the U.S. population,” said study author Dr. Jiang He.

“We highly recommend practitioners to try to adhere to the new guidelines,” said He, who is chairman of epidemiology with the Tulane University School of Public Health and Tropical Medicine in New Orleans.

Some debate has occurred since adoption of the new guidelines regarding risks associated with blood pressure medication, said Dr. Clyde Yancy, chief of cardiology with the Northwestern University Feinberg School of Medicine in Chicago.

“Whenever there is a change in the approach to a common problem that requires an entire rethink of what has been a standard of care, there’s going to be some argument, some pushback, some hesitancy,” Yancy said.

But the new study reveals that the potential benefits of the new guidelines far outweigh the risks, he added.

The researchers reported that doctors need to treat 70 people to prevent one case of heart attack or stroke, and 129 people to prevent one death.

By comparison, treatment numbers that would increase side effects associated with blood pressure medication are much higher:

  • 468 people would need to be treated to cause one case of kidney injury.
  • 603 treated to cause one case of dangerously low blood pressure.
  • 1,171 treated to cause one person to pass out from a fall in blood pressure.
  • 1,189 treated to cause one case of abnormal electrolyte levels in the blood.

“The number needed to harm is hundreds or thousands, but the number needed to benefit is not only less than 100, but it’s exactly in keeping with the threshold set for statin therapy for primary prevention,” Yancy said.

“We’ve already decided when the number needed to treat to improve outcomes is less than 100, that qualifies an important public health imperative,” Yancy explained

He noted that 9 percent of people now considered to have high blood pressure would not be recommended for medication. Instead, they would try to lower their blood pressure through exercise, diet and other lifestyle changes.

Under the new guidelines, everyone with stage 1 high blood pressure should be evaluated for heart disease. Only those with heart disease or at high risk for developing it during the next decade would be prescribed drugs.

“The majority of people who are newly diagnosed ought to be able to be managed with non-drug regimens,” Yancy said. “We should not dismiss those approaches. There is substantial benefit to be had by appropriately deploying these lifestyle and dietary changes.”

Both Yancy and He said doctors should embrace the new guidelines, since many more lives would be saved.

“If your reason for reluctance is about risk, we’ve done the risk assessment,” Yancy said. “The data reflect one big step toward better implementation and better outcomes.”

The new study was published online May 23 in JAMA Cardiology.

More information

The American Heart Association has more about high blood pressure.

© 2018 HealthDay. All rights reserved.

Posted: May 2018

Tagged with:

About author

Related Articles